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Abstract 
Background: Klebsiella pneumoniae is the most common pathogen of community‑acquired pyogenic liver abscess 
in East Asia. Diabetes mellitus (DM) is a well‑established risk factor for K. pneumoniae liver abscess (KPLA). However, 
reports regarding the emergence of KPLA in non‑diabetic patients are limited.
Results: A total 230 patients with KPLA from a medical center in Taiwan were identified retrospectively. The rate 
of DM in patients with KPLA was 44.4 % in 2011, 57.9 % in 2012, 44.9 % in 2013, 35.0 % in 2014, and 53.5 % in 2015. 
Diabetic patients had higher rate of gas‑forming abscesses than non‑diabetic patients, but the clinical outcomes were 
not different. The six virulent capsular types (K1, K2, K5, K20, K54, and K57) accounted for 90.2 % of all K. pneumoniae 
isolates, and were more prevalent in non‑diabetic than diabetic patients (93.9 vs 85.9 %, P = 0.048). The six virulent 
capsular types were also more prevalent in the group with optimal glycemic levels (Non‑DM and DM with HbA1c 
level <7 %) than the DM group with HbA1c level ≥7 % (93.9 vs 84.3 %, P = 0.022).
Conclusion: Klebsiella pneumoniae liver abscess has emerged in non‑diabetic patients in Taiwan. Diabetic patients 
were at higher risk of acquiring gas‑forming abscesses. Non diabetic patients and diabetic patients with optimal gly‑
cemic levels are more susceptible to the virulent capsular types of K. pneumoniae.
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Background
Klebsiella pneumoniae is known as a major pathogen 
to cause nosocomial urinary-tract infection, pneumo-
nia, and intra-abdominal infections worldwide [1–3], 
as well as community-acquired pyogenic infection in 
Taiwan [4–6]. In the past three decades in East Asian 
countries (especially Taiwan, Korea, and Singapore), K. 
pneumoniae has emerged as the major cause of commu-
nity-acquired pyogenic liver abscess [7–15]. A distinct 
invasive syndrome of Klebsiella pneumoniae liver abscess 
(KPLA) with extrahepatic complications involving 
endophthalmitis, infection in the central nervous system 
as well as septic metastatic lesions in other organs, have 
also been reported [16–18]. The prevalent KPLA is now 
considered as an endemic disease in Taiwan [14, 19]. The 
mortality rate due to KPLA has decreased in Taiwan in 
recent years [14, 16]. However, metastatic complications 
with ocular or neurological involvement from KPLA 
could result in catastrophic disability and a poor long-
term prognosis [18]. The high economic burden resulting 
from KPLA is also the concern [9].
Diabetes mellitus (DM) is a well-established risk fac-
tor for KPLA. The percentage of DM in KPLA patients 
was as high as 60–78.4 % in previous studies in Taiwan 
[12, 16, 17, 20]. Patients with underlying DM are also 
more susceptible to septic metastatic complications from 
KPLA [12, 17, 20, 21]. Recently, we reported that diabetic 
patients with uncontrolled glycemia were more suscep-
tible to metastatic complications from KPLA than those 
with controlled glycemia [11]. In contrast to the previous 
studies, we found that about half of the patients did not 
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have DM from January 2007 to January 2012 [11]. How-
ever, the emergence of KPLA in non-diabetic patients 
has received little attention in the literature. The relation-
ship between the capsular types of K. pneumoniae and 
different glycemic status of patients with KPLA remains 
undetermined.
In this study, we aimed to investigate the clinical char-
acteristics of KPLA patients and the associated capsular 
types of K. pneumoniae strains in Taiwan in the recent 
5  years. Particular attention was focused on the emer-
gence of KPLA in non-diabetic patients.
Methods
Study population and data collection
This retrospective analysis enrolled the patients diag-
nosed with KPLA who were admitted to Taipei Veterans 
General Hospital (a 2900-bed tertiary medical center) 
from January 2011 to December 2015. We excluded 
patients aged  <20  years, patients with polymicrobial or 
nosocomial infections, or patients who developed liver 
abscess after invasive procedure, including trans-hepatic 
arterial chemoembolization or stent replacement over 
common bile duct. The medical records of patients 
with KPLA were reviewed by two infection specialists. 
Information regarding clinical features, underlying dis-
eases, laboratory findings, origin and nature of the liver 
abscesses, imaging findings, treatment and outcomes 
were collected. Assessment of blood glycemic status was 
based on hemoglobin A1c (HbA1c) levels at the time of 
infection or as close to the time of infection as possible, 
within 1 month before this episode of KPLA. Since newly 
diagnosed DM is not unusual in patients with KPLA, it 
is a common practice to check HbA1c in patients with 
KPLA in Taiwan. This study was approved by Institu-
tional Review Board of Taipei Veterans General Hospital.
Definition
An episode of KPLA was defined as a culture-confirmed 
K. pneumoniae isolated from an abscess or blood and ≥1 
liver abscess, detected by sonography or computed 
tomography. Only the first episode of KPLA in an indi-
vidual patient diagnosed at our hospital during the study 
period was included. The diagnosis of DM was according 
to the criteria published by the American Diabetes Asso-
ciation in 2012: HbA1c level ≥6.5 %, symptoms of hyper-
glycemia with a random plasma glucose ≥200 mg/dL, or 
2-h plasma glucose ≥200 mg/dL during an oral glucose 
tolerance test, or fasting plasma glucose  ≥126  mg/dL 
[23]. “Cryptogenic KPLA” was that in which no obvious 
extra-hepatic source of infection could be identified. “Bil-
iary-tract origin of a liver abscess” was defined if the clin-
ical features of cholecystitis/cholangitis or extra-hepatic 
biliary ductal abnormalities were identified upon radi-
ography [11]. “Chronic lung disease” included chronic 
obstructive pulmonary disease, bronchiectasis, or any 
structural lung disease with the exception of broncho-
genic carcinoma. Chronic kidney disease was defined as 
baseline serum creatinine ≥2  mg/dL. “Metastatic infec-
tion” was defined as a distant site of infection isolated 
with the same pathogen (K. pneumoniae) as in a pyogenic 
liver abscess. “Multiple liver abscesses” were defined 
as ≥3 abscesses detected by imaging. The Acute Physiol-
ogy and Chronic Health Evaluation II (APACHE II) score 
was estimated within 48 h after hospital admission.
Microbiology laboratory procedures
The VITEK 2 system (bioMérieux, Marcy l’Etoile, France) 
or matrix-assisted laser desorption-ionization time-of-
flight mass spectrometry (bioMérieux SA, Marcy l’Etoile, 
France) was used to confirm bacterial identifications 
among the available isolates. To determine the capsular 
types of K. pneumoniae, we undertook cps genotyping by 
the polymerase chain reaction (PCR) detection of K sero-
type-specific alleles at wzy and wzx loci, including K1, 
K2, K5, K20, K54, and K57, as described previously [16]. 
These capsular types are thought to be the most closely 
associated with community invasive disease or patho-
genicity [24].
Statistical analyses
Data were analyzed using SPSS ver. 17 (SPSS, Chicago, 
IL, USA). Chi square or Fisher’s exact tests were carried 
out for categorical data. The two-tailed Student’s t test or 
Mann–Whitney U test was done for numerical data. A P 
value < 0.05 was considered statistically significant.
Results
Clinical characteristics of KPLA in patients with or 
without DM
A total of 255 patients diagnosed with KPLA during the 
study period were enrolled. 25 patients were excluded: 6 
patients were infected by multidrug-resistant K. pneumo-
niae nosocomially, 6 patients developed a liver abscess 
after trans-hepatic arterial chemoembolization for 
hepatocellular carcinoma, 1 patient developed a liver 
abscess after replacing a stent over common bile duct, 
and 12 patients had polymicrobial liver abscess. Of the 
remaining 230 patients (149 males), the mean age was 
63.8  ±  15.5  years. The overall in-hospital mortality of 
KPLA was 3.5 % (8 patients). More than half the patients 
(n = 120, 52.2 %) in this study period did not have DM. 
The rate of DM in patients with KPLA was 44.4  % in 
2011, 57.9 % in 2012, 44.9 % in 2013, as low as 35.0 % in 
2014, and 53.5 % in 2015.
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To further characterize non-diabetic patients with 
KPLA, Table  1 details the comparisons between dia-
betic and non-diabetic patients with KPLA. More male 
patients were in diabetic than non-diabetic group (72.7 
vs 57.5  %, P  =  0.016). Diabetic patients had a signifi-
cantly higher Charlson comorbidity index (2.4  ±  1.9 
vs 1.1  ±  1.8, P  <  0.001) than those without diabetes. 
The prevalence of gas-forming abscess (16.4 vs 1.7  %, 
P  =  <  0.001) was significantly higher in diabetic than 
non-diabetic patients. The APACHE II score was sig-
nificantly higher in diabetic patients (14.5  ±  7.4 vs 
12.3 ±  6.9, P =  0.018), whereas rate of ICU admission, 
length of hospital stay, and in-hospital mortality did not 
differ between the two groups. Interestingly, capsular 
types K1 and K2 tended to be more prevalent in non-
diabetic than diabetic patients (81.7 vs 70.7 %, P = 0.057).
Clinical characteristics of KPLA in non‑diabetic patients 
and diabetic patients with optimal glycemic level
We compared the clinical characteristics between non-
diabetic patients and diabetic patients with optimal 
Table 1 Clinical characteristics of  diabetic and  non-dia-
betic patients with KPLA
Data are presented as mean ± SD or frequency with percentage (%)
a 115 isolates were available for genotyping






Age in years 64.1 ± 16.3 63.5 ± 14.6 0.779
Male 69 (57.5) 80 (72.7) 0.016
Charlson score 1.1 ± 1.8 2.4 ± 1.9 <0.001
Underlying disease
 Malignancy 11 (9.2) 10 (9.1) 0.984
 Alcoholism 4 (3.3) 8 (7.3) 0.180
 Chronic kidney disease 4 (3.3) 8 (7.3) 0.180
 Liver cirrhosis 5 (4.2) 1 (0.9) 0.215
 Congestive heart failure 8 (6.7) 5 (4.5) 0.487
 Chronic lung disease 5 (4.2) 5 (4.5) 1.000
 Cerebrovascular accident 11 (9.2) 8 (7.3) 0.602
APACHE II score 12.3 ± 6.9 14.5 ± 7.4 0.018
HbA1c 5.6 ± 1.2 9.2 ± 2.6 <0.001
Capsular type K1 and K2 94 (81.7)a 70 (70.7)b 0.057
Wild‑type antibiotic susceptibility 113 (94.2) 103 (93.6) 0.867
Origin 0.749
 Cryptogenic 103 (85.8) 96 (87.3)
 Biliary tract origin 17 (14.2) 14 (12.7)
Abscess location 0.408
 Right lobe 77 (64.2) 79 (71.8)
 Left lobe 21 (17.5) 17 (15.5)
 Both lobes 22 (18.3) 14 (12.7)
Abscess size 0.419
 <5 cm 51 (42.5) 41 (37.3)
 ≥5 cm 69 (57.5) 69 (62.7)
Gas‑forming abscess 2 (1.7) 18 (16.4) <0.001
Multiple abscesses 18 (15.0) 15 (13.6) 0.768
Metastatic infection 6 (5.0) 12 (10.9) 0.096
Outcomes
 ICU admission 23 (19.2) 28 (25.5) 0.252
 Hospital days 26.9 ± 16.5 32.3 ± 38.5 0.178
 Mortality 4 (3.4) 4 (3.6) 0.910
Table 2 Clinical characteristics of patients with KPLA strat-
ified by  non-diabetic and  diabetic with  optimal glycemic 
control
Data are presented as mean ± SD or frequency with percentage (%)
a 115 isolates were available for genotyping







Age in years 64.1 ± 16.3 69.5 ± 12.9 0.166
Male 69 (57.5) 13 (68.4) 0.369
Charlson score 1.1 ± 1.8 2.0 ± 1.4 0.047
Underlying disease
 Malignancy 11 (9.2) 3 (15.8) 0.408
 Alcoholism 4 (3.3) 0 (0) 1.000
 Chronic kidney disease 4 (3.3) 3 (15.8) 0.054
 Liver cirrhosis 5 (4.2) 0 (0) 1.000
 Congestive heart failure 8 (6.7) 2 (10.5) 0.627
 Chronic lung disease 5 (4.2) 1 (5.3) 0.593
 Cerebrovascular accident 11 (9.2) 0 (0) 0.361
 APACHE II score 12.3 ± 6.9 14.9 ± 8.4 0.136
 Capsular type K1 and K2 94 (81.7)a 12 (75.0)b 0.506
 Wild‑type antibiotic  
susceptibility
113 (94.2) 17 (89.5) 0.355
Origin 1.000
 Cryptogenic 103 (85.8) 17 (89.5)
 Biliary tract origin 17 (14.2) 2 (10.5)
Abscess location 0.937
 Right lobe 77 (64.2) 12 (63.2)
 Left lobe 21 (17.5) 4 (21.1)
 Both lobes 22 (18.3) 3 (15.8)
Abscess size 0.369
 <5 cm 51 (42.5) 6 (31.6)
 ≥5 cm 69 (57.5) 13 (68.4)
Gas‑forming abscess 2 (1.7) 3 (15.8) 0.018
Multiple abscesses 18 (15.0) 3 (15.8) 1.000
Metastatic infection 6 (5.0) 1 (5.3) 1.000
Outcomes
 ICU admission 23 (19.2) 3 (15.8) 1.000
 Hospital days 26.9 ± 16.5 28.1 ± 21.1 0.786
 Mortality 4 (3.4) 0 (0) 1.000
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glycemic level (HbA1c <7 %) (Table 2). Diabetic patients 
with optimal glycemic level had significantly higher 
Charlson comorbidity index than those without diabe-
tes (2.0 ± 1.4 vs 1.1 ± 1.8, P = 0.047). Interestingly, gas-
forming abscesses (15.8 vs 1.7  %, P  =  0.018) occurred 
more frequently even in diabetic patients with optimal 
glycemic level than those without diabetes.
Distribution of K. pneumoniae capsular genotypes 
in patients with different glycemic levels
Among 230 patients with KPLA, 214 isolates were avail-
able for capsular genotyping. Table 3 shows the distribu-
tion of capsular types in patients with different glycemic 
levels. Overall, the six virulent capsular types (K1, K2, 
K5, K20, K54, and K57) accounted for 90.2 % (n = 193) 
of all K. pneumoniae isolates. Capsular type K1 (n = 121, 
56.5 %) and K2 (n = 43, 20.1 %) were the most prevalent 
strains. We also found that 54.5  % (66/121) K1 isolates 
and 65.1  % (28/43) K2 isolates were isolated from non-
diabetic patients, respectively. Capsular type K1 and K2 
isolates had the trend to be more prevalent in non-dia-
betic than diabetic patients (81.7 vs 70.7  %, P =  0.057). 
The six virulent capsular types (K1, K2, K5, K20, K54, and 
K57) were significantly more prevalent in non-diabetic 
than diabetic patients (93.9 vs 85.9 %, P = 0.048).
To further explore the association of glycemic status 
with the distribution of capsular types, non-diabetic and 
diabetic patients with HbA1c level <7 % were defined as 
the group with optimal glycemic level. Diabetic patients 
with HbA1c level ≥7 % were defined as the non-optimal 
glycemic level group. We found that the six virulent cap-
sular types (K1, K2, K5, K20, K54, and K57) were signifi-
cantly more prevalent in the group with optimal glycemic 
level than the group without optimal glycemic level (93.9 
vs 84.3 %, P = 0.022).
Discussion
The present study demonstrated the emergence of KPLA 
in non-diabetic patients as well as the distribution of cap-
sular types of K. pneumoniae in Taiwan. In our 5-year 
cohort study, more than half of the patients did not have 
underlying DM. While the rate of gas-forming abscess 
was significantly higher in diabetic than non-diabetic 
patients, the clinical outcomes did not differ. Capsular 
types K1, K2, K5, K20, K54, and K57 accounted for the 
majority of all the K. pneumoniae isolates. These six vir-
ulent capsular types were significantly more prevalent 
in the group with optimal glycemic level than that with 
non-optimal glycemic level.
In one study conducted from July 1991 to June 1998 in 
two medical centers (including our hospital) in Taiwan, 
DM was present in 78.4  % (105/134) of patients with 
KPLA [12]. In one recent review article, 63 % (323/512) 
of patients with KPLA had underlying DM in Taiwan 
[22]. However, in our present study, DM accounted for 
only 47.8 % (110/230) of KPLA patients in the previous 
5-year period (2011–2015). These findings further imply 
that DM is not a prerequisite for the development of 
KPLA anymore. As an endemic disease in Taiwan, phy-
sicians should be vigilant about the potential of acquir-
ing KPLA in patients without underlying DM. Despite 
the emergence of KPLA in non-diabetic patients, we still 
found a higher rate of gas-forming abscess in diabetic 
patients. This finding corresponded to our former study 
that indicated the important role of glycemic level in clin-
ical characteristics of KPLA [11].
The comparison of clinical characteristics between 
non-diabetic patients and diabetic patients with optimal 
glycemic level (HbA1c <7 %) has never been addressed. 
We found that gas-forming abscess was significantly 
more prevalent in diabetic patients with optimal glyce-
mic levels than those without diabetes. But the clinical 
outcome were not different between these two groups. 
These results might suggest that previous glycemic expo-
sure still had adverse effects upon immunity against sub-
sequent bacterial infection.
The literature has demonstrated that K1 and K2 were 
the major capsular types causing KPLA [22]. Fang et  al. 
has demonstrated that six capsular types (K1, K2, K5, 
K20, K54, and K57) accounted for 92  % of the K. pneu-
moniae isolates during 1997–2005 in a medical center 
in Taiwan [16]. Similarly, our study disclosed that the six 
capsular types accounted for 93.9  % of K. pneumoniae 
Table 3 Distribution of  capsular types of  K. pneumoniae 
isolates in  non-diabetic and  diabetic patients with  differ-
ent HbA1c levels
Data are presented as frequency with percentage (%)
a Comparison between Non-DM and DM
b Comparison between group with optimal glycemic level (Non-DM + DM with 









K1 66 (57.4) 12 (75.0) 43 (51.8) 0.787 0.266
K2 28 (24.3) 0 (0) 15 (18.1) 0.094 0.557
K5 6 (5.2) 0 (0) 3 (3.6) 0.510 1.000
K20 1 (0.9) 1 (6.3) 4 (4.8) 0.098 0.210
K54 4 (3.5) 1 (6.3) 4 (4.8) 0.736 0.737




108 (93.9) 15 (93.8) 70 (84.3) 0.048 0.022
Others 7 (6.1) 1 (6.3) 13 (15.7) 0.048 0.022
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isolates. However, reports regarding the impact of gly-
cemic status on the distribution of capsular types of K. 
pneumoniae isolates are limited. In the current study, K1 
isolates predominated in non-DM group and DM groups 
with different HbA1c levels. This result again documented 
that capsular type K1 is the major virulent factor causing 
KPLA. Notably, we found that 65.1 % (28/43) of all K2 iso-
lates occurred in non-diabetic patients, which was higher 
than the previous report (4/10, 40  %) by Yu et  al. [25]. 
These findings imply that K. pneumoniae capsular type K2 
is sufficiently virulent to cause severely invasive infection, 
even in a healthy host. Whether or not the prevalent K2 
strains account for the increasing proportion of KPLA in 
non-diabetic patients remained uncertain. Further studies 
to explore this issue are needed.
We also found that six virulent capsular types were 
more prevalent in non-DM than DM group. In terms of 
the association of glycemic status with the distribution 
of capsular types, the group with optimal glycemic level 
(Non-DM and DM with HbA1c level <7 %) was infected 
with these six virulent capsular types more frequently 
than the DM group with HbA1c level  ≥7  %. It implies 
that non-DM or healthy persons with KPLA are infected 
primarily with virulent K. pneumoniae capsular types, 
whereas other capsular types with a relatively lower 
virulence can still cause liver abscesses, mostly in DM 
patients without optimal glycemic control [25].
Our study has some limitations. First, this study was 
conducted in a tertiary medical center in northern Tai-
wan, and all data were collected from medical records 
retrospectively. Further studies should be carried out 
prospectively in other regions or countries to confirm 
our findings. Second, not all K. pneumoniae isolates were 
determined for capsular genotyping. Finally, the number 
of diabetic patients with optimal glycemic level was rela-
tively small in comparison to other groups. Despite these 
limitations, our study was the first to identify the distri-
bution of K. pneumoniae capsular types in patients with 
KPLA according to the different glycemic status.
Conclusions
In conclusion, DM accounted for less than 50 % of KPLA 
patients in the 5-year cohort in Taiwan. Gas-forming 
abscesses from KPLA occurred more frequently in dia-
betic patients. The prevalent virulent capsular types of 
K. pneumoniae in patients with optimal glycemic level 
play an important role in the emergence of KPLA in non-
diabetic patients. Vaccination for prevention of KPLA is 
not available currently in Taiwan, and it is expected that 
the virulent K. pneumoniae isolates will continuously 
occur in hosts without traditional risk factors. Further 
study with emphasis on the characteristics of KPLA in 
non-diabetic patients is warranted. The knowledge of 
distribution of capsular types among patients with differ-
ent glycemic levels will be crucial for the disease control 
and prevention in the future.
Abbreviations
DM: diabetes mellitus; KPLA: Klebsiella pneumoniae liver abscess; HbA1c: 
hemoglobin A1c; APACHE II: Acute Physiology and Chronic Health Evaluation 
II.
Authors’ contributions
YTL contributed to study concept and design, data interpretation, and 
manuscript drafting; CC and WCF contributed to data acquisition and analysis; 
CC contributed to manuscript drafting and data interpretation; and YTL and 
FDW contributed to the supervision of this investigation. All authors read and 
approved the final manuscript.
Author details
1 Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. 
2 Division of Infectious Diseases, Department of Medicine, Taipei Veterans 
General Hospital, Number 201, Section 2, Shih‑Pai Road, Beitou District, 
Taipei 11217, Taiwan. 3 School of Medicine, National Yang‑Ming University, 
Taipei, Taiwan. 4 Institute of Emergency and Critical Care Medicine, National 
Yang‑Ming University, Taipei, Taiwan. 
Acknowledgements
We thank the Medical Science and Technology Building of Taipei Veterans 
General Hospital for providing experimental space and facilities. Some result 
from this study was presented as a paper poster at the ASM’s Interscience 
Conference of Antimicrobial Agents and Chemotherapy (ICAAC 2015) in 
Sandiego, California, United States.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets during and/or analyzed during the current study available from 
the corresponding author on reasonable request. Identifying patient data will 
not be shared.
Ethics approval and consent to participate
The study was approved by the Institution Review Board of Taipei Veterans 
General Hospital. The written informed consent form was waived.
Funding
This work was supported by grants from the Ministry of Science and Technol‑
ogy in Taiwan (MOST 103‑2314‑B‑075 ‑078 ‑MY2), Taipei Veterans General 
Hospital (V104B‑001, and V105B‑001), and Szu‑Yuan Research Foundation of 
Internal Medicine (105001).
Received: 28 July 2016   Accepted: 3 October 2016
References
 1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epi‑
demiology, taxonomy, typing methods, and pathogenicity factors. Clin 
Microbiol Rev. 1998;11:589–603.
 2. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk 
factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med. 
2009;122:866–73.
 3. Wu HS, Wang FD, Tseng CP, Wu TH, Lin YT, Fung CP. Characteristics of 
healthcare‑associated and community‑acquired Klebsiella pneumoniae 
bacteremia in Taiwan. J Infect. 2012;64:162–8.
 4. Lin YT, Jeng YY, Chen TL, Fung CP. Bacteremic community‑acquired 
pneumonia due to Klebsiella pneumoniae: clinical and microbiological 
characteristics in Taiwan, 2001–2008. BMC Infect Dis. 2010;10:307.
Page 6 of 6Chuang et al. Gut Pathog  (2016) 8:46 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 5. Lin YT, Chen TL, Siu L, Hsu SF, Fung CP. Clinical and microbiological char‑
acteristics of community‑acquired thoracic empyema or complicated 
parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J 
Clin Microbiol Infect Dis. 2010;29:1003–10.
 6. Lin YT, Wang YP, Wang FD, Fung CP. Community‑onset Klebsiella pneumo-
niae pneumonia in Taiwan: clinical features of the disease and associated 
microbiological characteristics of isolates from pneumonia and naso‑
pharynx. Front Microbiol. 2015;9:122.
 7. Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused 
by K1 serotype Klebsiella pneumoniae in Korea. J Infect. 2007;54:578–83.
 8. Chan DS, Archuleta S, Llorin RM, Lye DC, Fisher D. Standardized outpa‑
tient management of Klebsiella pneumoniae liver abscesses. Int J Infect 
Dis. 2013;17:e185–8.
 9. Wu PF, Chang YY, Lin YT, Wang FD, Chan YJ, Fung CP. Clinical characteris‑
tics and economic consequence of Klebsiella pneumoniae liver abscess in 
Taiwan. J Microbiol Immunol Infect. 2015;48(2):190–7.
 10. Lin YT, Liu CJ, Yeh YC, Chen TJ, Fung CP. Ampicillin and amoxicillin use 
and the risk of Klebsiella pneumoniae liver abscess in Taiwan. J Infect Dis. 
2013;208:211–7.
 11. Lin YT, Wang FD, Wu PF, Fung CP. Klebsiella pneumoniae liver abscess in 
diabetic patients: association of glycemic control with the clinical charac‑
teristics. BMC Infect Dis. 2013;13:56.
 12. Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella 
pneumoniae liver abscess: is serotype K1 an important factor for compli‑
cated endophthalmitis? Gut. 2002;50:420–4.
 13. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene 
in Klebsiella pneumoniae strains causing primary liver abscess and septic 
metastatic complications. J Exp Med. 2004;199:697–705.
 14. Tsai FC, Huang YT, Chang LY, Wang JT. Pyogenic liver abscess as endemic 
disease, Taiwan. Emerg Infect Dis. 2008;14:1592–600.
 15. Wang YP, Liu CJ, Chen TJ, Lin YT, Fung CP. Proton pump inhibitor use 
significantly increases the risk of cryptogenic liver abscess: a population‑
based study. Aliment Pharmacol Ther. 2015;41:1175–81.
 16. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae 
genotype K1: an emerging pathogen that causes septic ocular or central 
nervous system complications from pyogenic liver abscess. Clin Infect 
Dis. 2007;45:284–93.
 17. Lee SS, Chen YS, Tsai HC, et al. Predictors of septic metastatic infection 
and mortality among patients with Klebsiella pneumoniae liver abscess. 
Clin Infect Dis. 2008;47:642–50.
 18. Lin YT, Liu CJ, Chen TJ, Fung CP. Long‑term mortality of patients with 
septic ocular or central nervous system complications from pyogenic 
liver abscess: a population‑based study. PLoS ONE. 2012;7:e33978.
 19. Lin YT, Liu CJ, Chen TJ, et al. Pyogenic liver abscess as the initial 
manifestation of underlying hepatocellular carcinoma. Am J Med. 
2011;124:1158–64.
 20. Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneu-
moniae in Taiwan. Clin Infect Dis. 1998;26:1434–8.
 21. Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, Hsu WM. Endogenous Klebsiella 
endophthalmitis associated with pyogenic liver abscess. Ophthalmology. 
2007;114:876–80.
 22. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver 
abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–7.
 23. Diagnosis and classification of diabetes mellitus. Diabetes Care. 
2012;35(Suppl 1):S64–71.
 24. Turton JF, Perry C, Elgohari S, Hampton CV. PCR characterization and 
typing of Klebsiella pneumoniae using capsular type‑specific, variable 
number tandem repeat and virulence gene targets. J Med Microbiol. 
2010;59(Pt 5):541–7.
 25. Yu WL, Chan KS, Ko WC, Lee CC, Chuang YC. Lower prevalence of diabetes 
mellitus in patients with Klebsiella pneumoniae primary liver abscess 
caused by isolates of K1/K2 than with non‑K1/K2 capsular serotypes. Clin 
Infect Dis. 2007;45:1529–30.
